CVR 38204874Entrepreneurial company (IVS)Konsulentbistand vedrørende informationsteknologi (620200)Svanevænget 30, 2100 København ØFounded 23 Nov 2016
Compare withsimilar companiesanother companyits industry
Label & Dose IVS
CVR holds no employment figures for this company.
The newest trades with a company on a side are on the latest property trades.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Cite as: Label & Dose IVS, https://dandex.ai/company/38204874/label-dose. Source: Dandex, from CVR, read 22 Nov 2026.
Dandex is Danish Company Data. Connect it once and ask about Label & Dose IVS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Dandex has an MCP server at https://dandex.ai/mcp and a REST API at https://dandex.ai/api/v1.
Set up DandexGross profit
-5.6K
DKK, annual report 2020
Result
-3.1K
DKK, annual report 2020
Equity
-43.5K
DKK, annual report 2020
HippoCorn ApSCVR 37237744, 100% of capital and votes, until 29 Oct 2021
Morten Lund Nielsenuntil 29 Oct 2021
No current owner is registered.
CVR 37237744100% of capital and votes23 Nov 2016 to 29 Oct 2021
Label & Dose IVS holds no Danish company now.
Danish companies held at 5% or more, from the CVR owner register (ejerregister), and their holdings one level down. Foreign holdings are not in CVR.
CVR 3817109720% to under 25% of capital and votes30 Dec 2016 to 5 Aug 2020
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2020, DKK: Gross profit -5.6K, Result for the year -3.1K
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2020, DKK: Total assets 2.1K, Equity -43.5K
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|
| Gross profit | -52 | 19 | -47 | -6 |
| Result for the year | -53 | +17 | -41 | -3 |
| Equity | -53 | 1 | -40 | -43 |
| Total assets | 23 | 47 | 5 | 2 |
| Employees (average) | Not reported | Not reported | 0 | 0 |
Not every period is a full year: 2017 covers 13 months (23 Nov 2016 to 31 Dec 2017). Changes against it compare periods of different length.
Amounts in DKK.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| FoundingCashPaid in 100 | None | 100 | None | 100 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The company's own figures, in DKK, from the annual reports filed in XBRL.
| DKK thousands | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|
| Gross profit growth (vækst i bruttofortjeneste) | Not reportednote 1 | n.m.note 2 | -347.6% | n.m.note 2 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | |||
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | |||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | |||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | |||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | |||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | |||
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | |||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | |||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
How each credit metric is calculated:
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
Source: CVR, read 22 Nov 2026.
6 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Virksomheden er opløst ved erklæring efter selskabslovens § 216, jf. lov om erhvervsdrivende virksomheder § 20
Direktion:
Fratrådte:
Morten Lund Nielsen, den 29.10.2021.
Direktion:
Fratrådte:
Jakob Mikkel Hansen, den 25.02.2019.
Den under 28.11.2018 fremsendte anmodning til Sø- og Handelsrettens Skifteretsafdeling om opløsning af virksomheden, er tilbagetaget.
Vedtægter ændret: 10.01.2019
Direktion:
Tiltrådte:
Jakob Mikkel Hansen, den 23.11.2016, Morten Lund Nielsen, den 23.11.2016.
Virksomheden tegnes af en direktør.
Anmodning om opløsning, jf. selskabslovens § 225 sendt til Sø- og Handelsrettens Skifteretsafdeling den 28.11.2018
Direktion:
Fratrådte:
Jakob Mikkel Hansen, den 28.11.2018, Morten Lund Nielsen, den 28.11.2018.
Ny adresse: c/o Hippocorn, Svanevænget 30, 2100 København Ø
Stiftelsesdato: 23.11.2016.
Virkningsdato: 23.11.2016.
Seneste vedtægtsdato: 23.11.2016.
Kapital:
kr. 100,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 100,00 til kurs 100,00, fuldt indbetalt.
Stifter:
CVR-NR. 37237744 HippoCorn IVS, c/o Jakob Mikkel Hansen, Artillerivej 86, 5. TH., 2300 København S, den 23.11.2016.
Direktion:
Jakob Mikkel Hansen, den 23.11.2016, Morten Lund Nielsen, den 23.11.2016.
Selskabet kan tegnes af den samlede direktion.
Første regnskabsår:
23.11.2016 - 31.12.2017.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er at medvirke til udvikling af design, arkitektur og markedsføringsservice, samt virksomhed der efter ledelsens skøn er forbundet hermed.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 22 Nov 2026.
What Pro holds for Label & Dose IVS:
Have Pro? Sign in.
P-number 1021950358Svanevænget 30, 2100 København Ø